Regulation · Regulation
JAMA is launching a medical journal just for AI research
On 15 October 2026 the JAMA Network, which publishes one of the world's biggest medical journals, announced JAMA AI. It will open for research papers in early 2027 and check them with peer review, the usual expert vetting. Rating: Announced only.
How far away is this?
An announcement in a JAMA editorial; the journal hasn't published anything yet, so it's Announced only.
Get the weekly How Far
One email every Friday morning (Sydney time) on which medical AI actually reached patients, and what it means for you. Free, in plain English.
Where is it approved?
| Region | Regulator | Status | Notes |
|---|---|---|---|
| United States | FDA | Not applicable | Not a medical product. |
| European Union | CE mark / EMA | Not applicable | Not a medical product. |
| United Kingdom | MHRA | Not applicable | Not a medical product. |
| Australia | TGA | Not applicable | Not a medical product. |
Publishing news: there's no product to approve. "Register not searched yet" means we haven't searched that regulator's register; it doesn't mean the product is or isn't available. Approval in one country isn't approval in another.
What is it?
JAMA AI will be the network's 14th journal, online only. It will publish research on AI in health care, plus apps, wearables, digital imaging and the effects of tech like social media on health. Its first editor is Dr Roy Perlis of Massachusetts General Hospital and Harvard Medical School. Unusually, it plans to use AI to help assess and review papers, with human editors still making every decision.
What's the evidence?
JAMA AI will be the 14th journal in the JAMA Network, launching in early 2027 and starting to accept submissions then.[1]
Evidence stage: Announced only · #c1
The editors say it will use rigorous peer review, human editorial review and selection, and high standards for reporting, the same as the network's other journals.[1]
Evidence stage: Announced only · #c2
Its focus areas include generative and agentic AI, clinical decision support, AI diagnostics and therapeutics, and methods for testing safety, effectiveness and impact on patients.[2]
Evidence stage: Announced only · #c3
What does it mean for me?
A lot of AI health claims come from company blogs and posts. A major journal giving AI its own home with expert vetting means more of those claims should be tested in public. When you read about a medical AI, it's worth asking: has it been published in a peer-reviewed journal?
What could I ask my doctor?
- Has the AI tool you're using been tested in a published study?
These are general starting points, not a recommendation to choose any particular test or treatment.
Short videos, under a minute
We make short, plain-English videos about AI in medicine, including what it can't do yet. Follow How Far for the next one.
Change history
- : First published.
General information only, not medical advice. Talk to your doctor about your situation. AI-assisted source check. Not clinically reviewed.
References
- JAMA (2026): Announcing JAMA AI, a new journal from the JAMA Network (editorial). doi.org (2026). Editorial. https://doi.org/10.1001/jama.2026.22425
- JAMA Network media release (15 October 2026). media.jamanetwork.com (2026). Official. https://media.jamanetwork.com/post/announcing-jama-ai-a-new-journal-from-the-jama-network
Publisher shown as the website hosting each source. Dates are given where the source label includes them.